Saturday , November 2 2024
Home / Tag Archives: johnson and johnson

Tag Archives: johnson and johnson

5 Coronavirus Stocks to Look Out For as COVID-19 Spread Continues

A few stocks, including some of the ones below, are being classified as COVID-19 stocks because of their potential to rise even as the pandemic worsens.Apart from the obvious health effects, the current coronavirus pandemic has already depleted financial markets all over the world. As the outbreak continues to spread and the world records a lot more confirmed cases, these economic effects are also going to continue. Many companies are already recording heavy losses and many of the world’s...

Read More »

JNJ, MRNA Stocks Down Around 1.5%, J&J and Moderna to Produce Possible COVID-19 Vaccine

The U.S government has partnered Johnson & Johnson and Moderna to facilitate the production of the possible COVID-19 vaccine in large quantities.The government of the United States of America alongside Johnson & Johnson (NYSE: JNJ) and Moderna Inc (NASDAQ: MRNA) have partnered to produce in more substantial amounts possible vaccine for COVID-19 before the real vaccines hit the market. As per report, the U.S. government is also working to partner with not lesser than two other...

Read More »

5 Companies Lead the Race in Producing the First COVID-19 Vaccine

Five pharmaceutical companies across the globe lead the race in producing the first approved COVID-19 vaccine. Wall Street is likewise on alert for banking on the first company to produce an efficient one.As the battle against the spread of coronavirus outbreak across the world intensifies, many companies are working to put themselves at the forefront in producing viable COVID-19 vaccine.Producing a vaccine for human testing and adoption to address the Coronavirus outbreak remains as crucial...

Read More »

Johnson & Johnson Stock Up 7%, Human Testing of Coronavirus Vaccine to Begin by September

Johnson & Johnson after the announcement of the test of its coronavirus vaccine, JNJ stock has continued to surge, rising over 7%.Multinational pharmaceutical firm Johnson & Johnson (NYSE: JNJ) on Monday announced that human trial of its experimental vaccine for ravaging coronavirus will start September and would be ready for emergency use authorization early next year.After Johnson and Johnson made the announcement, the firm’s JNJ stock has continued to surge, rising over 7%.Johnson...

Read More »